Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

ViewRay® to Participate in Upcoming Conferences

ViewRay
Posted on: 28 Feb 18

CLEVELAND, Feb. 27, 2018 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that Chris Raanes, Chief Executive Officer, and Ajay Bansal, Chief Financial Officer, are scheduled to participate in two upcoming investor conferences.

The first conference is the 2018 BTIG Healthcare Conference in Snowbird, Utah. This conference will allow institutional investors to meet with the Company but does not include a formal presentation.

Event:      

2018 BTIG Healthcare Conference

Date:          

Thursday, March 1, 2018

Participants:    

Ajay Bansal, Chief Financial Officer

The second conference is the Cowen and Company 38th Annual Health Care Conference in Boston, MA. This conference includes a formal presentation with a breakout session and will also allow institutional investors to meet with the Company.

Event:            

Cowen and Company 38th Annual Health Care Conference

Date:             

Tuesday, March 13, 2018

Time:            

10:40am ET

Participants:    

Chris Raanes, Chief Executive Officer, and Ajay Bansal, Chief Financial Officer

An audio webcast of the Company's presentation at the Cowen Health Care conference will be available by visiting the investor relations section of ViewRay's website at www.viewray.com. A replay of the webcast will be available for 7 days after the date of the presentation.

About ViewRay
ViewRay®, Inc. (Nasdaq: VRAY), designs, manufactures and markets the MRIdian® radiation therapy system. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purposely built to deliver high-precision radiation without unnecessary beam distortion, and consequently, help to mitigate skin toxicity and other safety concerns that may otherwise arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 28/02/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.